AVP and Hyponatremia: Hyponatraemia, defined as a serum sodium concentration below 135 mmol/L, was found in this study in 38.2% during AVP treatment, while the study by Alakeel et al. showed an increase in hyponatraemia incidence to 49.4% at 48 h into AVP administration.